Skip to main
MDT

Medtronic (MDT) Stock Forecast & Price Target

Medtronic (MDT) Analyst Ratings

Based on 21 analyst ratings
Buy
Strong Buy 33%
Buy 38%
Hold 29%
Sell 0%
Strong Sell 0%

Bulls say

Medtronic is a global leader in medical technology, with a diverse portfolio of products and a strong presence in both mature and emerging markets. The company's recent product launches and pipeline developments show potential for continued revenue growth and margin improvement. While there are some risks to consider, such as market competition and potential regulatory challenges, the overall outlook for Medtronic is positive.

Bears say

Medtronic is a large medical device company that manufactures and sells therapeutic devices for various chronic diseases. Despite its wide product portfolio and global presence, the company's recent earnings and guidance appear to be conservative and new product launches may not have enough impact to counter any potential market slowdowns. Additionally, clinical study results for the Intibia System and Medicare coverage for the Symplicity Spyral RDN System have not met expectations, which could hinder future revenue growth. Based on these factors, the analyst believes the company's stock is currently overvalued.

Medtronic (MDT) has been analyzed by 21 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 38% recommend Buy, 29% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Medtronic and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Medtronic (MDT) Forecast

Analysts have given Medtronic (MDT) a Buy based on their latest research and market trends.

According to 21 analysts, Medtronic (MDT) has a Buy consensus rating as of Sep 8, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $104.86, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $104.86, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Medtronic (MDT)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.